These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8116181)

  • 1. Characterization of protective antigens and the protective immune response.
    Roth JA
    Vet Microbiol; 1993 Nov; 37(3-4):193-9. PubMed ID: 8116181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal immunity: implications for vaccine development.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Immunobiology; 1992 Feb; 184(2-3):157-79. PubMed ID: 1587541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-12 as an adjuvant for induction of protective antibody responses.
    Metzger DW
    Cytokine; 2010; 52(1-2):102-7. PubMed ID: 20650650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune system stimulation by probiotics.
    Perdigon G; Alvarez S; Rachid M; Agüero G; Gobbato N
    J Dairy Sci; 1995 Jul; 78(7):1597-606. PubMed ID: 7593855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens.
    Igietseme JU; Eko FO; He Q; Black CM
    Expert Rev Vaccines; 2004 Feb; 3(1):23-34. PubMed ID: 14761241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines for mucosal immunity to combat emerging infectious diseases.
    van Ginkel FW; Nguyen HH; McGhee JR
    Emerg Infect Dis; 2000; 6(2):123-32. PubMed ID: 10756145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral cytotoxic T lymphocyte induction and vaccination.
    Rouse BT; Norley S; Martin S
    Rev Infect Dis; 1988; 10(1):16-33. PubMed ID: 2451265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB.
    Verma V; Tan W; Puth S; Cho KO; Lee SE; Rhee JH
    J Transl Med; 2016 May; 14(1):135. PubMed ID: 27184355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretory immunoglobulin A: from mucosal protection to vaccine development.
    Corthésy B; Spertini F
    Biol Chem; 1999 Nov; 380(11):1251-62. PubMed ID: 10614817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the protective immune response to Yersinia pseudotuberculosis infection in mice vaccinated with an LcrV-secreting strain of Lactococcus lactis.
    Daniel C; Titecat M; Poiret S; Cayet D; Boutillier D; Simonet M; Sirard JC; Lemaître N; Sebbane F
    Vaccine; 2016 Nov; 34(47):5762-5767. PubMed ID: 27742220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.
    Nordøy T; Husebekk A; Aaberge IS; Jenum PA; Samdal HH; Flugsrud LB; Kristoffersen AC; Holte H; Kvaløy S; Kolstad A
    Bone Marrow Transplant; 2001 Oct; 28(7):681-7. PubMed ID: 11704791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of SIV capsid-specific CTL and mucosal sIgA in mice immunized with a recombinant S. typhimurium aroA mutant.
    Valentine PJ; Meyer K; Rivera MM; Lipps C; Pauza D; Maziarz RT; So M; Heffron F
    Vaccine; 1996 Feb; 14(2):138-46. PubMed ID: 8852411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal immunity and vaccination.
    Holmgren J
    FEMS Microbiol Immunol; 1991 Dec; 4(1):1-9. PubMed ID: 1815705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens.
    Karem KL; Bowen J; Kuklin N; Rouse BT
    J Gen Virol; 1997 Feb; 78 ( Pt 2)():427-34. PubMed ID: 9018066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice.
    Wu SF; Liao CL; Lin YL; Yeh CT; Chen LK; Huang YF; Chou HY; Huang JL; Shaio MF; Sytwu HK
    Vaccine; 2003 Sep; 21(25-26):3919-29. PubMed ID: 12922127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of secretory immunity and memory at mucosal surfaces.
    Brandtzaeg P
    Vaccine; 2007 Jul; 25(30):5467-84. PubMed ID: 17227687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with the major secretory protein of Legionella induces humoral and cell-mediated immune responses and protective immunity across different serogroups of Legionella pneumophila and different species of Legionella.
    Blander SJ; Horwitz MA
    J Immunol; 1991 Jul; 147(1):285-91. PubMed ID: 1711078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for the development of vaccines conferring broad-spectrum protection.
    Nagy G; Emody L; Pál T
    Int J Med Microbiol; 2008 Jul; 298(5-6):379-95. PubMed ID: 18485818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral stimulation of the immune system of the mucosa].
    Riedl-Seifert RJ; van Aubel A
    Fortschr Med; 1990 Jan; 108(3):47-56. PubMed ID: 2179084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of protective immune responses promoted by human antigen targets in a urogenital Chlamydia trachomatis mouse model.
    Olsen AW; Andersen P; Follmann F
    Vaccine; 2014 Feb; 32(6):685-92. PubMed ID: 24365515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.